Lysosomal zinc nanomodulation blocks macrophage pyroptosis for counteracting atherosclerosis progression
Science Advances · 2025
DOI: 10.1126/sciadv.adu3919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Ruizhi Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P. R. China. Hauptthemen laut MEDLINE: Zinc, Pyroptosis, Lysosomes, Atherosclerosis. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Macrophage pyroptosis has been identified as a critical pathological mechanism in inflammation-related atherosclerosis (AS). In this work, we have demonstrated that Zn 2+ features the strongest anti-inflammatory performance by screening 10 representative metal ions, and the MTC1 agonists can trigger lysosomal Zn 2+ release and inhibit pyroptosis in macrophages. Based on these findings, we further engineered a mucolipin TRP channel 1 (MTC1)–related therapeutic nanoplatform for endogenously triggering lysosomal zinc release to curb inflammation and block macrophage pyroptosis. This nanoplatform consists of mesoporous silica nanoparticles to deliver MTC1 agonists and carbon nanodots, which could synergistically exert antiatherosclerotic effect by scavenging toxic reactive oxygen species, inhibiting macrophage pyroptosis, modulating macrophage transition, and rebuilding atherosclerotic immune microenvironment. These findings demonstrate that macrophage pyroptosis can be efficiently blocked via leveraging self-lysosomal zinc pool, which provides the paradigm of lysosomal zinc modulation-involved nanotherapeutics for managing other inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P. R. China.
- Department of Ultrasound, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.
- State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, P. R. China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou 325000, P. R. China.
- Shanghai Institute of Materdicine, Shanghai 200051, P. R. China.
ORCID-Profile: Ruizhi Hu, Junchang Qin, Wei Feng, Xinran Song, Hui Huang, Chen Dai, Bo Zhang, Yu Chen
Zitieren
APA
Hu, R., Qin, J., Feng, W., Song, X., Huang, H., Dai, C., Zhang, B., & Chen, Y. (2025). Lysosomal zinc nanomodulation blocks macrophage pyroptosis for counteracting atherosclerosis progression. Science Advances. https://doi.org/10.1126/sciadv.adu3919
Vancouver
Hu R, Qin J, Feng W, Song X, Huang H, Dai C, et al. Lysosomal zinc nanomodulation blocks macrophage pyroptosis for counteracting atherosclerosis progression. Science Advances. 2025. doi:10.1126/sciadv.adu3919
BibTeX
@article{Hu2025,
author = {Hu, Ruizhi and Qin, Junchang and Feng, Wei and Song, Xinran and Huang, Hui and Dai, Chen and Zhang, Bo and Chen, Yu},
title = {Lysosomal zinc nanomodulation blocks macrophage pyroptosis for counteracting atherosclerosis progression},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adu3919}
}
EUVIMED